At a glance
ClinicalIndex Comparison RecordN/ACompleted· 81 enrolled
Drug / intervention
ApneaLink Sleep Screenerdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Validation of the ApneaLink Sleep Screener in a Suspected Sleep Disordered Breathing Population
In Brief
An observational study evaluating ApneaLink Sleep Screener for Obstructive Sleep Apnea. Completed, enrolled 81 participants across 1 site.
Detailed Summary
The primary endpoints for this study are that the AL validation will 1) achieve a sensitivity of greater than 80% for AHI values greater than or equal to 15, and 2) demonstrate a correlation coefficient of r=0.75 indicating strong correlation between the AHI of diagnostic PSG and AL.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsObstructive Sleep Apnea
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartJun 2006
First PostedJul 2006
Primary CompletionMar 2007
Study CompletionJul 2007
TodayJul 2026
First PostedJul 20, 2006
Enrollment StartJun 1, 2006
Primary CompletionMar 1, 2007
Study CompletionJul 1, 2007
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 19.9 years ago
Interventions
ApneaLink Sleep Screenerdevice
Device used to evaluate for the presence of OSA